Medtrail Technologies Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 05-12-2024
- Paid Up Capital ₹ 1.20 M
as on 05-12-2024
- Company Age 7 Year, 3 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 2.00 M
as on 05-12-2024
- Revenue 77.81%
(FY 2021)
- Profit 27.19%
(FY 2021)
- Ebitda 33.82%
(FY 2021)
- Net Worth -83.45%
(FY 2021)
- Total Assets -57.54%
(FY 2021)
About Medtrail Technologies
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.20 M.
The company currently has active open charges totaling ₹2.00 M.
Mohit Mittal and Vijayasimha Devarapally serve as directors at the Company.
- CIN/LLPIN
U74999DL2017PTC323701
- Company No.
323701
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Sep 2017
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Medtrail Technologies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohit Mittal  | Director | 14-Sep-2017 | Current |
| Vijayasimha Devarapally | Director | 14-Sep-2017 | Current |
Financial Performance of Medtrail Technologies.
Medtrail Technologies Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 77.81% increase. The company also saw a substantial improvement in profitability, with a 27.19% increase in profit. The company's net worth observed a substantial decline by a decrease of 83.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medtrail Technologies?
In 2020, Medtrail Technologies had a promoter holding of 99.93% and a public holding of 0.07%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Medtrail Procurement Services Private LimitedActive 4 years 7 monthsMohit Mittal and Vijayasimha Devarapally are mutual person
- Medtrail Labs Private LimitedActive 4 years 7 months
Mohit Mittal and Vijayasimha Devarapally are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 May 2021 | ₹2.00 M | Open |
How Many Employees Work at Medtrail Technologies?
Medtrail Technologies has a workforce of 6 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medtrail Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medtrail Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
